Literature DB >> 187211

Methotrexate plasma decay kinetics: possible alteration in patients undergoing gut sterilization.

P J Creaven, M H Cohen, L M Allen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 187211      PMCID： PMC2025215          DOI： 10.1038/bjc.1976.213

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  11 in total

1.  Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man.

Authors:  P R Leme; P J Creaven; L M Allen; M Berman
Journal:  Cancer Chemother Rep       Date:  1975 Jul-Aug

2.  The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man.

Authors:  E S Henderson; R H Adamson; V T Oliverio
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

3.  Pharmacokinetics of methotrexate.

Authors:  D H Huffman; S H Wan; D L Azarnoff; B Hogstraten
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

5.  Separation of methotrexate and nonmethotrexate components in rat plasma.

Authors:  R E Kates; T N Tozer
Journal:  J Pharm Sci       Date:  1973-12       Impact factor: 3.534

6.  Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid.

Authors:  D M Valerino; D G Johns; D S Zaharko; V T Oliverio
Journal:  Biochem Pharmacol       Date:  1972-03-15       Impact factor: 5.858

7.  Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

Authors:  G P Bodey; E A Gehan; E J Freireich; E Frei
Journal:  Am J Med Sci       Date:  1971-09       Impact factor: 2.378

8.  Antibiotics alter methotrexate metabolism and excretion.

Authors:  D S Zaharko; H Bruckner; V T Oliverio
Journal:  Science       Date:  1969-11-14       Impact factor: 47.728

9.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

Authors:  J W Yates; J F Holland
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

10.  Methotrexate in liver and bile after intravenous dosage in man.

Authors:  P J Creaven; H H Hansen; D A Alford; L M Allen
Journal:  Br J Cancer       Date:  1973-12       Impact factor: 7.640
View more
  4 in total

Review 1.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

Review 2.  [Cytostatica and small intestine (author's transl)].

Authors:  R Ecknauer; K Rommel
Journal:  Klin Wochenschr       Date:  1978-06-15

Review 3.  Clinical management of cytotoxic drug overdose.

Authors:  L L Thomas; M J Mertens; A E von dem Borne; C J van Boxtel; C H Veenhof; E P Veies
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jul-Aug

4.  High-dose methotrexate: preliminary evaluation of a pharmacokinetic approach.

Authors:  S Monjanel; J P Rigault; J P Cano; Y Carcassonne; R Favre
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.